基于PCNE分类法的2392份肿瘤科病历用药分析  

Drug Use in 2392 Oncology Medical Records Based on PCNE Classification

作　　者：胡吕萍 姜云达 杨忠英 徐彬 邓桂胜 HU Lyuping;JIANG Yunda;YANG Zhongying;XU Bin;DENG Guisheng(Dept.of Pharmacy,Chongming Branch of Xinhua Hospital,Shanghai 202150,China;Dept.of Respiratory,Chongming Branch of Xinhua Hospital,Shanghai 202150,China)

机构地区：[1]新华医院崇明分院药剂科,上海202150 [2]新华医院崇明分院呼吸科,上海202150

出　　处：《中国医院用药评价与分析》2021年第11期1383-1387,共5页Evaluation and Analysis of Drug-use in Hospitals of China

基　　金：国家重点研发计划项目(No.2020YFC2005500);上海市药学会科研项目(No.2019-YY-06);2019年上海市临床药学重点专科建设项目。

摘　　要：目的:了解新华医院崇明分院(以下简称“我院”)肿瘤科药物使用情况,为提高临床合理用药水平提供参考。方法:运用欧洲医药保健网(pharmaceutical care network Europe,PCNE)分类系统,分析2020年我院肿瘤科2392份病历中药物不合理使用情况。结果:2020年我院肿瘤科出院病历共2392份,其中348份病历发生药物相关问题(drug related problem,DRP),占14.55%。共发生DRP 392例次,参考PCNE分类系统,DRP问题类型方面,“治疗效果”“治疗安全性”和“其他方面”的DRP例次数及占比分别为92例次(占23.47%)、146例次(占37.24%)和154例次(占39.29%);DRP原因类型方面,例次数及占比排序居首位的为“药物选择”(253例次,占64.54%),其次为“剂量选择”(87例次,占22.19%);2020年1—12月我院肿瘤科DRP发生率呈降低趋势。结论:通过PCNE分类法分析总结,发现我院肿瘤科的药物使用存在一定的问题,临床药师仍需加强对抗肿瘤药的审核和干预,促进临床合理用药。OBJECTIVE:To investigate the drug use in oncology department in Chongming Branch of Xinhua Hospital(hereinafter referred to as“our Hospital”),so as to provide reference for improving the rational drug use in clinic.METHODS:According to the Pharmaceutical Care Network Europe(PCNE)classification system,the irrational use of drugs in 2392 medical records of oncology department in our hospital in 2020 was analyzed.RESULTS:In 2020,there were 2392 medical records discharged from oncology department,of which 348 medical records had drug related problem(DRP),accounting for 14.55%.A total of 392 case-times of DRP occurred,and with reference to the PCNE classification system,the number and percentage of DRP for Treatment Effectiveness,Treatment Safety and Other Aspects were 92 case-times(23.47%),146 case-times(37.24%)and 154 case-times(39.29%),respectively.In terms of the causes of DRP,the number of case-times and the percentage of causes for“drug selection”(253 case-times,64.54%)took the lead,followed by“dose selection”(87 case-times,22.19%).From Jan.to Dec.2020,the incidence of DRP in oncology department of our hospital showed the decreasing trend.CONCLUSIONS:Through the analysis and summary of PCNE classification,it is found that there are certain problems in drug use in oncology department of our hospital,and clinical pharmacists still need to strengthen the review and intervention of anti-tumor drugs to promote the rational drug use.

关 键 词：合理用药 PCNE 临床药师 医嘱审核 药物相关问题 

分 类 号：R97[医药卫生—药品]